• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在良性前列腺增生(BPH)中,尿道周围区域的雄激素浓度及其受体高于包膜下区域。

Androgen concentrations and their receptors in the periurethral region are higher than those of the subcapsular zone in benign prostatic hyperplasia (BPH).

作者信息

Monti S, Di Silverio F, Toscano V, Martini C, Lanzara S, Varasano P A, Sciarra F

机构信息

Department of Medical Pathophysiology, II Endocrinology, University La Sapienza, Rome, Italy.

出版信息

J Androl. 1998 Jul-Aug;19(4):428-33.

PMID:9733145
Abstract

Benign prostatic hyperplasia (BPH) is an androgen-dependent disease that initially develops in the inner prostate, where the highest concentrations of testosterone (T) and dihydrotestosterone (DHT) are found. In this study, we have evaluated the cytosolic androgen receptors (ARc), the nuclear androgen receptors (ARn), and the concentrations of T, DHT, and 3alpha-androstanediol (3alphaDiol) in BPH tissue to verify the existence of a possible correlation between androgens and their receptor concentrations. Prostatic samples, removed by suprapubic prostatectomy in 15 untreated patients, were sectioned in periurethral, intermediate, and subcapsular zones. Testosterone, DHT, and 3alphaDiol were evaluated by radioimmunoassay after extraction and purification on celite microcolumns, and ARc and ARn were evaluated by means of dextran-coated charcoal method. In total tissue, mean levels of DHT, T, and 3alphaDiol were 2,531+/-308, 260+/-36, and 403+/-35 pg/mg of DNA (mean+/-SE), respectively. Cytosolic androgen receptors, detectable in all cases, were 16+/-2.8 fmol/mg of protein (mean+/-SE), and ARn, detectable in 12 cases, were 108+/-15 fmol/mg of DNA (mean+/-SE). A linear correlation between DHT and 3alphaDiol, T and DHT, and 3alphaDiol and ARn was found. If the different regions are considered, the periurethral zone, site of the primitive BPH nodule, presents the highest levels of androgens and ARn with respect to the other regions. This relative hyperandrogenism may be responsible for the growth-promoting processes of this area, leading to urinary obstruction.

摘要

良性前列腺增生(BPH)是一种雄激素依赖性疾病,最初发生在前列腺内部,此处可检测到最高浓度的睾酮(T)和双氢睾酮(DHT)。在本研究中,我们评估了BPH组织中的胞质雄激素受体(ARc)、核雄激素受体(ARn)以及T、DHT和3α - 雄甾二醇(3αDiol)的浓度,以验证雄激素与其受体浓度之间是否存在可能的相关性。对15例未经治疗的患者经耻骨上前列腺切除术切除的前列腺样本,在尿道周围、中间和包膜下区域进行切片。通过在硅藻土微柱上进行提取和纯化后,采用放射免疫分析法评估睾酮、DHT和3αDiol,通过葡聚糖包被活性炭法评估ARc和ARn。在整个组织中,DHT、T和3αDiol的平均水平分别为2531±308、260±36和403±35 pg/mg DNA(平均值±标准误)。在所有病例中均可检测到的胞质雄激素受体为16±2.8 fmol/mg蛋白质(平均值±标准误),在12例病例中可检测到的ARn为108±15 fmol/mg DNA(平均值±标准误)。发现DHT与3αDiol、T与DHT以及3αDiol与ARn之间存在线性相关性。如果考虑不同区域,原始BPH结节所在的尿道周围区域相对于其他区域呈现出最高水平的雄激素和ARn。这种相对雄激素过多可能是该区域生长促进过程的原因,导致尿路梗阻。

相似文献

1
Androgen concentrations and their receptors in the periurethral region are higher than those of the subcapsular zone in benign prostatic hyperplasia (BPH).在良性前列腺增生(BPH)中,尿道周围区域的雄激素浓度及其受体高于包膜下区域。
J Androl. 1998 Jul-Aug;19(4):428-33.
2
Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamide.非那雄胺或氟他胺治疗诱导良性前列腺增生(BPH)组织尿道周围区表皮生长因子(EGF)含量普遍降低。
J Androl. 1997 Sep-Oct;18(5):488-94.
3
Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgens.良性前列腺增生组织中胰岛素样生长因子I(IGF-I)、IGF-II及I型受体的区域差异及其与前列腺内雄激素的相关性。
J Clin Endocrinol Metab. 2001 Apr;86(4):1700-6. doi: 10.1210/jcem.86.4.7413.
4
Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia.锯叶棕果实提取物(保前列)长期治疗对良性前列腺增生患者雄激素及表皮生长因子浓度和区域分布的影响。
Prostate. 1998 Oct 1;37(2):77-83. doi: 10.1002/(sici)1097-0045(19981001)37:2<77::aid-pros3>3.0.co;2-i.
5
Regional distribution of epidermal growth factor, testosterone and dihydrotestosterone in benign prostatic hyperplasia tissue.良性前列腺增生组织中表皮生长因子、睾酮和双氢睾酮的区域分布
Urol Res. 1995;23(6):387-90. doi: 10.1007/BF00698740.
6
Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.雄激素与雌激素:它们与人良性前列腺增生及正常前列腺的基质和上皮的相互作用。
J Steroid Biochem. 1983 Jul;19(1A):155-61.
7
Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells.雄激素受体激活对人良性前列腺增生细胞的抗炎作用。
J Endocrinol. 2012 Jul;214(1):31-43. doi: 10.1530/JOE-12-0142. Epub 2012 May 4.
8
Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer.前列腺内的睾酮和二氢睾酮。第一部分:良性前列腺增生和前列腺癌患者中的浓度和测定方法。
BJU Int. 2012 Jan;109(2):176-82. doi: 10.1111/j.1464-410X.2011.10651.x. Epub 2011 Oct 12.
9
[Measurement of T and DHT contents in normal and diseased human prostate tissues].[正常及病变人类前列腺组织中睾酮和双氢睾酮含量的测定]
Zhonghua Wai Ke Za Zhi. 2000 Jul;38(7):545-7.
10
Effects of two different medical treatments on dihydrotestosterone content and androgen receptors in human benign prostatic hyperplasia.两种不同医学治疗方法对人良性前列腺增生中双氢睾酮含量及雄激素受体的影响。
J Steroid Biochem. 1988;30(1-6):395-9. doi: 10.1016/0022-4731(88)90130-6.

引用本文的文献

1
Tailoring prostate cancer external beam radiotherapy for patients with lower urinary tract symptoms.为下尿路症状患者量身定制前列腺癌体外放射治疗
World J Urol. 2025 Jun 7;43(1):361. doi: 10.1007/s00345-025-05730-1.
2
Review of the Roles and Interaction of Androgen and Inflammation in Benign Prostatic Hyperplasia.雄激素与炎症在良性前列腺增生中的作用及相互关系的研究进展。
Mediators Inflamm. 2020 Oct 28;2020:7958316. doi: 10.1155/2020/7958316. eCollection 2020.
3
The androgen receptor plays different roles in macrophage-induced proliferation in prostate stromal cells between transitional and peripheral zones of benign prostatic hypertrophy.
雄激素受体在良性前列腺增生移行区和外周区巨噬细胞诱导的前列腺基质细胞增殖中发挥不同作用。
EXCLI J. 2017 Jun 22;16:939-948. doi: 10.17179/excli2017-335. eCollection 2017.
4
[Interventional treatment of benign prostatic hyperplasia : Embolization of the testicular vein].良性前列腺增生的介入治疗:睾丸静脉栓塞术
Radiologe. 2017 Aug;57(8):652-658. doi: 10.1007/s00117-017-0275-2.
5
Inflammatory mediators in the development and progression of benign prostatic hyperplasia.在良性前列腺增生的发生和发展中的炎症介质。
Nat Rev Urol. 2016 Sep 30;13(10):613-26. doi: 10.1038/nrurol.2016.168.
6
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer.雄激素受体与良性前列腺增生和前列腺癌中的免疫炎症
Clin Investig (Lond). 2014 Oct 1;4(10):935-950. doi: 10.4155/cli.14.77.
7
Androgen receptor roles in the development of benign prostate hyperplasia.雄激素受体在良性前列腺增生中的作用。
Am J Pathol. 2013 Jun;182(6):1942-9. doi: 10.1016/j.ajpath.2013.02.028. Epub 2013 Apr 6.